Table 4 Clinical characteristics of 14 recurrent patients
Patient no. | Peritoneal cytology | Histologic grade | Depth of invasion | Cervical involvement | Initial failure sites | Time to recurrence (months) | Treatment | Status |
|---|---|---|---|---|---|---|---|---|
1 | Positive | 1 | >2/3 | Mucosal | Nodes | 24 | Not done | DODa (40) |
2 | Positive | 1 | <1/3 | Mucosal | Peritoneum | 9 | Chemo | AWDa (39) |
3 | Positive | 2 | <1/3 | Absent | Lung | 19 | Chemo | DOD (22) |
4 | Positive | 3 | >2/3 | Mucosal | Lung | 6 | Chemo | DOD (19) |
5 | Positive | 3 | >2/3 | Absent | Nodes, bone | 24 | RTa | DOD (26) |
6 | Negative | 1 | 1/3–2/3 | Absent | Vagina | 4 | RT | NEDa (116) |
7 | Negative | 1 | 1/3–2/3 | Absent | Vagina | 26 | RT | NED (64) |
8 | Negative | 1 | >2/3 | Stromal | Lung, vagina | 4 | RT, Chemo | NED (72) |
9 | Negative | 1 | Absent | Absent | Systemic | 26 | RT, Chemo | DOD (41) |
10 | Negative | 1 | >2/3 | Stromal | Lung | 13 | Surgery | NED (57) |
11 | Negative | 2 | >2/3 | Absent | Lung | 33 | Not done | DOD (42) |
12 | Negative | 2 | >2/3 | Absent | Spleen | 24 | Surgery | AWD (47) |
13 | Negative | 3 | >2/3 | Absent | Bone | 11 | Not done | DOD (13) |
14 | Negative | 3 | >2/3 | Absent | Lung | 31 | Unknown | DOD (40) |
